FDA Investigator Addam S Reynolds

Addam S Reynolds has conducted inspections on 60 sites in 2 countries as of 09 Jul 2012. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
60
Last Inspection Date:
09 Jul 2012
Investigator Role:
FDA Investigator
Redica ID:
100005732
Countries of Inspections:
United States of America, Canada
FDA Investigators that have inspected at least one site in common with Addam S Reynolds:
Adetutu M Gidado, Alberto A Viciedo, Amy L Singer, Amy M Codella, Amy M Cramer, Ankur C Patel, Anna M Brannen, Anna R Kwilas, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony J Donato, Ashutosh Rao, PhD, Asia D Clark, Atul J Agrawal, Barbara J Maulfair, Barbara Jwilimczyk Macri, Bei Yu, Byungja E Marciante, Cassandra L Abellard, Charles J Chacko, Chiang Syin, PhD, Christina P Burkhart, Craig W Swanson, Cynthia F Kleppinger, MD, Daniel J Grabicki, Dawn L Wydner, Deborah B Nixon, Denise M Visco, Investigator, Devon Jenkins, Dhaval H Patel, Donald C Obenhuber, PhD, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Elaine E Gilfillan, Emest F Bizjak, Emily A Baldwin, Emily A Walters, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Esteban Beltran, Eufemia G Gonzalez, Frank J Marciniak, Frederick F Razzaghi, Gobiga Vanniyasingam, Guerlain Ulysse, Haley H Seymour, Helen B Ricalde, Helen Verdel, Jacqueline S Warner, James R Birkenstamm, Janet A Rajan, Jay B Shah, Jay T Wong, Jean M Kelahan, Jean M Mulinde, MD, Jeffrey J Ebersole, Jenny Sung, Jessica M Monteiro, Jessica S Estriplet, Jogy George, Jonathan S Helfgott, Jonee J Mearns, Jose M Cayuela, Jose Martinez, Jr, Jose Ohernandez Guzman, Joseph F Mcginnis, RPh, Josh Renzo N Ramilo, Joy Rkozlowski Klena, Juanita P Versace, Justin A Boyd, Justine Tomasso, Karen E D'orazio, Karishma G Gopaul, Keith M Reilly, Kelli F Dobilas, Kelly I Anderson, Kenneth M Gordon, Kevin Obrien, Kimberly L Schultz, Kinh Q Mac, Ko U Min, Kristen E Rescigno, Kristin M Abaonza, Kristy A Zielny, Lauren L Vajo, Lawrence R Johnson, Lcr Jayt Wong, Li Li, Liatte Kreuger, PharmD, Linda Thai, Lisa M Bellows, Loretta Nemchik, Marcelo O Mangalindan, Jr, Marcia Gelber, Marea K Harmon, Margaret M Sands, Maria A Bienkowski, Maria A Reed, Maria Estrella, Melissa T Roy, Meredith L Sheridan, Meyer J Slobotsky, Michael R Klapal, Michael Serrano, Michelle A Marsh, Michelle M Parisi, Monika Borkowska, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Nikki S Ramirez, Nimmy Mathews, Nina Yang, Patrick C Klotzbuecher, Patsy J Domingo, Paul L Bellamy, Paul L Figarole, Jr, Paul Mouris, Peter R Lenahan, Philip F Istafanos, DMV, MS, Puspa Suresh Jayasekara, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Richard E Needham, Robert J Martin, Rose Ljean Mary, Ruben C Quintana, Russell J Glapion, Ruth A Williams, Samantha J Bradley, Samir C Gala, Sarah Forney, Satheesh K Podaralla, Sayyem H Akbar, Schultz, Sean G Casey, Shelby N Turner, Shirley S Wen, Sinai I Davis, Stephanie T Durso, Stephen J Koniers, Stephen J Mottola, Stephenie M Ortiz, Suchan Kim, Susanna E Ford, Tamil Arasu, PhD, Tara G Bizjak, Tara R Gooen, Toyin B Oladimeji, Tyanna N Hadley, Unnee Ranjan, Valerie C Reed, Victoria Spivak, Wayne J Meyer, William R Chang, Xiaoping Guan, Yumi J Hiramine, Yvesna C Blaise, Yvins Dezan, Zhongren Wu

Addam S Reynolds's Documents

Publish Date Document Type Title
November, 2010 FDA 483 OHM LABORATORIES INC. - Form 483, 2010-11-10
July, 2010 FDA 483 OHM LABORATORIES INC. - Form 483, 2010-07-14
September, 2011 EIR ISP Sutton Laboratories - EIR, 2011-09-01
June, 2012 EIR Tris Pharma Inc - EIR, 2012-06-15
July, 2009 FDA 483 Sunrise Pharmaceutical Inc - Form 483, 2009-07-30
December, 2008 EIR Givaudan Flavors Corporation - EIR, 2008-12-18
May, 2011 FDA 483 Tris Pharma Inc - Form 483, 2011-05-06
June, 2010 FDA 483 Sonar Products, Inc. - Form 483, 2010-06-21
March, 2010 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2010-03-01
February, 2011 FDA 483 Catalent Pharma Solutions, LLC - Form 483, 2011-02-18
March, 2011 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2011-03-25
November, 2009 FDA 483 Bentley Laboratories, LLC - Form 483, 2009-11-18
June, 2011 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2011-06-30
April, 2012 FDA 483 Jacobus Pharmaceutical Company, Inc - Form 483, 2012-04-16
May, 2009 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2009-05-19
April, 2012 FDA 483 Everest Life Sciences LLC - Form 483, 2012-04-16
May, 2012 FDA 483 Excelsior Medical LLC - Form 483, 2012-05-14
June, 2012 FDA 483 Tris Pharma Inc - Form 483, 2012-06-15
August, 2009 FDA 483 Paragon Packaging Inc. - Form 483, 2009-08-19
August, 2011 FDA 483 Renaissance Lakewood LLC - Form 483, 2011-08-10
February, 2011 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2011-02-17
August, 2012 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2012-08-28
January, 2012 FDA 483 Bentley Laboratories, LLC - Form 483, 2012-01-30
December, 2010 FDA 483 Sunrise Pharmaceutical Inc - Form 483, 2010-12-20
October, 2011 EIR US Pharma Lab Inc. - EIR, 2011-10-21
June, 2011 FDA 483 Response Hikma Pharmaceuticals USA, Inc. - Form 483R, 2011-07-21
April, 2012 FDA 483 Response Everest Life Sciences LLC - Form 483R, 2012-04-30

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more